181 related articles for article (PubMed ID: 32162825)
1. The Critical Role of Tumor Size in Predicting Prognosis for T1 Colon Cancer.
Dai W; Mo S; Xiang W; Han L; Li Q; Wang R; Xu Y; Cai G
Oncologist; 2020 Mar; 25(3):244-251. PubMed ID: 32162825
[TBL] [Abstract][Full Text] [Related]
2. Tumor Size as a Critical Prognostic Factor in T1-2 Stage Esophageal Cancer.
Wu Z; Yu B
Gastroenterol Res Pract; 2020; 2020():2796943. PubMed ID: 32879626
[TBL] [Abstract][Full Text] [Related]
3. Tumor size as a significant prognostic factor in T1 gastric cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
Xiao X; Gao B; Pang S; Wang Z; Jiang W; Wang W; Lin R
BMC Gastroenterol; 2023 Apr; 23(1):121. PubMed ID: 37046218
[TBL] [Abstract][Full Text] [Related]
4. Prognostic accuracy of different lymph node staging system in predicting overall survival in stage IV colon cancer.
Han L; Mo S; Xiang W; Li Q; Wang R; Xu Y; Dai W; Cai G
Int J Colorectal Dis; 2020 Feb; 35(2):317-322. PubMed ID: 31858220
[TBL] [Abstract][Full Text] [Related]
5. Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancer.
Liu Q; Ma Y; Luo D; Cai S; Li Q; Li X
Int J Colorectal Dis; 2018 Aug; 33(8):1107-1114. PubMed ID: 29770845
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of tumor size in stage T1 gastric cancer.
Chen Y; Jia Y; Peng Z; Wang G
World J Surg Oncol; 2022 Apr; 20(1):135. PubMed ID: 35477526
[TBL] [Abstract][Full Text] [Related]
7. Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
Di Narzo AF; Tejpar S; Rossi S; Yan P; Popovici V; Wirapati P; Budinska E; Xie T; Estrella H; Pavlicek A; Mao M; Martin E; Scott W; Bosman FT; Roth A; Delorenzi M
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25246611
[TBL] [Abstract][Full Text] [Related]
8. Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database.
Huang B; Feng Y; Zhu L; Xu T; Huang L; Cai G
Int J Surg; 2016 Sep; 33 Pt A():157-63. PubMed ID: 27491969
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1-2N0M0, Estrogen Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Invasive Breast Cancer: A Population-Based Analysis.
Ding S; Wu J; Lin C; Andriani L; Goh C; Chen W; Li Y; Shen K; Zhu L
Oncologist; 2019 Nov; 24(11):e1014-e1023. PubMed ID: 31019021
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study.
Zheng P; Chen Q; Li J; Jin C; Kang L; Chen D
J Surg Res; 2020 Jan; 245():475-482. PubMed ID: 31446189
[TBL] [Abstract][Full Text] [Related]
11. Mucinous Adenocarcinomas Histotype Can Also be a High-Risk Factor for Stage II Colorectal Cancer Patients.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai S
Cell Physiol Biochem; 2018; 47(2):630-640. PubMed ID: 29794464
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
[No Abstract] [Full Text] [Related]
14. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
[TBL] [Abstract][Full Text] [Related]
15. Cavity Formation is a Prognostic Indicator for Pathologic Stage I Invasive Lung Adenocarcinoma of ≥3 cm in Size.
Chen C; Fu S; Ni Q; Yiyang W; Pan X; Jing J; Zhao H; Rui W
Med Sci Monit; 2019 Nov; 25():9003-9011. PubMed ID: 31772147
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.
Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G
Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267
[TBL] [Abstract][Full Text] [Related]
17. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
[TBL] [Abstract][Full Text] [Related]
18. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
Pagès F; Mlecnik B; Marliot F; Bindea G; Ou FS; Bifulco C; Lugli A; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Angelova M; Vasaturo A; Maby P; Church SE; Angell HK; Lafontaine L; Bruni D; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Meyers JP; Paustian C; Feng Z; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Sargent DJ; Fox BA; Galon J
Lancet; 2018 May; 391(10135):2128-2139. PubMed ID: 29754777
[TBL] [Abstract][Full Text] [Related]
19. A robust gene signature for the prediction of early relapse in stage I-III colon cancer.
Dai W; Li Y; Mo S; Feng Y; Zhang L; Xu Y; Li Q; Cai G
Mol Oncol; 2018 Apr; 12(4):463-475. PubMed ID: 29377588
[TBL] [Abstract][Full Text] [Related]
20. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
